First Trust Amex Biotech Index Fund (FBT): Price and Financial Metrics ETF
FBT Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $164.69 | 52-week high | $183.60 |
| Prev. close | $162.00 | 52-week low | $141.38 |
| Day low | $163.56 | Volume | 14,400 |
| Day high | $164.88 | Avg. volume | 25,399 |
| 50-day MA | $158.98 | Dividend yield | 0.72% |
| 200-day MA | $168.62 |
FBT Stock Price Chart Interactive Chart >
First Trust Amex Biotech Index Fund (FBT) ETF Bio
The investment objective of the First Trust Amex Biotech Index Fund ETF seeks to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
FBT ETF Info
| Issuer | First Trust Portfolios |
| Expense Ratio | 0.55% |
| Underlying Index | NYSE Arca Biotechnology Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 1.03B |
| Net Asset Value (NAV) | $162.45 |
| Options? | Yes |
| Total Holdings | 32 |
FBT Top Holdings
| Symbol | Company | % of Total |
| ACAD | ACADIA Pharmaceuticals Inc. | 4.61% |
| NBIX | Neurocrine Biosciences Inc. | 4.24% |
| ALNY | Alnylam Pharmaceuticals Inc. | 3.97% |
| EXAS | Exact Sciences Corporation | 3.84% |
| EXEL | Exelixis Inc. | 3.7% |
| INCY | Incyte Corporation | 3.66% |
| ALKS | Alkermes Plc | 3.61% |
| GMAB | Genmab A/S (ADR) | 3.58% |
| BNTX | BioNTech SE (ADR) | 3.56% |
| UTHR | United Therapeutics Corporation | 3.56% |
FBT Price Returns
| 1-mo | 5.16% |
| 3-mo | -5.34% |
| 6-mo | -5.88% |
| 1-year | 8.55% |
| 3-year | 21.45% |
| 5-year | 1.16% |
| YTD | -0.91% |
| 2024 | 5.88% |
| 2023 | 2.55% |
| 2022 | -4.83% |
| 2021 | -2.26% |
| 2020 | 12.96% |
FBT Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||